DRUG

amlexanox

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for amlexanox

ALS 2

Mediator Outcome Score Tier Lit. status Trial
TBK1 ALS 0.289 High partial evidence none
TBK1 frontotemporal dementia 0.208 Mid novel signal none

Clinical trials

3 registered trials for amlexanox

Source: ClinicalTrials.gov

← All drugs